Alembic has a cumulative total of 137 ANDA approvals (118 final approvals and 19 tentative approvals) from USFDA... Dec 03
Gavreto is a once-daily, oral precision therapy designed to selectively target RET alterations, including fusions and mutations... Dec 03
This test may help identify recovering patients who could potentially be serum and plasma donors for developing treatments for COVID-19... Dec 03
-Advertisements-